verapamil has been researched along with Penile Induration in 68 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Penile Induration: A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil and dexamethasone iontophoresis is a safe and reliable treatment resolving painful erections in the acute phase of PD." | 3.78 | Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience. ( Coloma, A; Fernández Arjona, M; Formoso, T; Garrido Abad, P; Herranz, LM; Jiménez, M; Prieto, MD; Suárez, C, 2012) |
| "To evaluate the effects of the transdermal electromotive administration of verapamil and dexamethasone on plaque size, penile deviation, pain, erectile function and capacity for vaginal penetration in patients with Peyronie's disease." | 3.72 | Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. ( Capelli, G; Di Stasi, SM; Giannantoni, A; Jannini, EA; Storti, L; Vespasiani, G; Virgili, G, 2003) |
| "Peyronie's disease is a condition that results in the development of penile plaques that can lead to penile curvature, pain, and erectile dysfunction, making sexual activity difficult." | 3.01 | Non-surgical therapies for Peyronie's disease. ( Blair, Y; Dahm, P; Edwards, ME; Ergun, O; Hwang, EC; Jung, JH; Risk, MC; Rosenberg, JE, 2023) |
| "Peyronie's disease is still a therapeutic dilemma for the urologist." | 2.77 | Pharmacological therapy in patients diagnosed with Peyronie's disease. ( Ceban, E; Geavlete, P; Halal, AA, 2012) |
| "Verapamil or saline was injected directly into the Peyronie's plaque once a week for 6 months." | 2.69 | Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. ( Benet, A; Melman, A; Rehman, J, 1998) |
| "Medical treatment of Peyronie's disease (PD) in terms of intralesional therapy is still a matter of debate." | 2.61 | Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis. ( Albersen, M; Cacciamani, G; Cocci, A; Kessler, TM; Morgia, G; Russo, GI; Serefoglu, EC; Verze, P, 2019) |
| "Peyronie's disease is a collagen wound healing disorder of the penis that negatively affects the quality of life of afflicted men." | 2.53 | Peyronie's Disease: Intralesional Therapy and Surgical Intervention. ( Aliperti, LA; Mehta, A, 2016) |
| "Nonsurgical treatment of Peyronie's disease clearly has a place in the armamentarium of the practicing urologist." | 2.42 | Review of current nonsurgical management of Peyronie's disease. ( Levine, LA, 2003) |
| "Peyronie's disease has no known cause; recent understanding of the molecular mechanisms involved and the development of an animal model will aid the medical management of early disease." | 2.42 | The management of Peyronie's disease. ( Minhas, S; Ralph, DJ, 2004) |
| "Verapamil was detected in 71." | 1.32 | Tunica albuginea tissue analysis after electromotive drug administration. ( Cole, A; Estrada, CR; Levine, LA; Shou, W, 2003) |
| "Peyronie's disease is the most frequent cause of penile curvature and occurs particularly in middle-age patients." | 1.31 | A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. ( Fusco, F; Imbimbo, C; Longo, N; Mirone, V; Palmieri, A; Tajana, G, 2002) |
| "No verapamil was detected in any tunical specimens." | 1.31 | Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. ( Badwan, K; Martin, DJ; Mulhall, JP; Parker, M, 2002) |
| "Peyronie's disease is a fibromatosis of the tunica albuginea which affects up to 2% of men." | 1.31 | Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents. ( Anderson, MS; Lubrano, T; Mulhall, JP; Shankey, TV, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (13.24) | 18.2507 |
| 2000's | 27 (39.71) | 29.6817 |
| 2010's | 27 (39.71) | 24.3611 |
| 2020's | 5 (7.35) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, E | 2 |
| Wang, J | 1 |
| Levine, LA | 14 |
| Rosenberg, JE | 1 |
| Ergun, O | 1 |
| Hwang, EC | 1 |
| Risk, MC | 1 |
| Jung, JH | 1 |
| Edwards, ME | 1 |
| Blair, Y | 1 |
| Dahm, P | 1 |
| Sadagopan, A | 1 |
| Karaszewski, J | 1 |
| Zareba, I | 1 |
| Guszczyn, T | 1 |
| Darewicz, B | 1 |
| Palka, J | 1 |
| Asali, M | 2 |
| Favilla, V | 2 |
| Russo, GI | 3 |
| Zucchi, A | 1 |
| Siracusa, G | 1 |
| Privitera, S | 2 |
| Cimino, S | 2 |
| Madonia, M | 2 |
| Cai, T | 1 |
| Cavallini, G | 6 |
| Liguori, G | 1 |
| D'Achille, G | 1 |
| Silvani, M | 1 |
| Franco, G | 1 |
| Verze, P | 2 |
| Palmieri, A | 3 |
| Torrisi, B | 1 |
| Mirone, V | 3 |
| Morgia, G | 3 |
| Cacciamani, G | 1 |
| Cocci, A | 1 |
| Kessler, TM | 1 |
| Serefoglu, EC | 1 |
| Albersen, M | 1 |
| Gallo, L | 1 |
| Sarnacchiaro, P | 1 |
| Castelli, T | 1 |
| La Vignera, S | 1 |
| Condorelli, R | 1 |
| Calogero, AE | 1 |
| Farina, FP | 1 |
| Paulis, G | 5 |
| Giorgio, GD | 1 |
| Quattrocchi, S | 1 |
| Brancato, T | 5 |
| Alvaro, R | 4 |
| Jordan, GH | 1 |
| Carson, CC | 1 |
| Lipshultz, LI | 1 |
| Tan, RB | 1 |
| Sangkum, P | 1 |
| Mitchell, GC | 1 |
| Hellstrom, WJ | 4 |
| Sherer, BA | 1 |
| Warrior, K | 1 |
| Alizadeh, M | 1 |
| Karimi, F | 1 |
| Fallah, MR | 1 |
| Wolff, B | 1 |
| Peyronnet, B | 1 |
| Cattarino, S | 1 |
| Mozer, P | 1 |
| Renard-Penna, R | 1 |
| Phé, V | 1 |
| Bitker, MO | 1 |
| Rouprêt, M | 1 |
| Aliperti, LA | 1 |
| Mehta, A | 1 |
| Tuygun, C | 1 |
| Ozok, UH | 1 |
| Gucuk, A | 1 |
| Bozkurt, IH | 1 |
| Imamoglu, MA | 1 |
| Beley, S | 1 |
| Shirazi, M | 1 |
| Haghpanah, AR | 1 |
| Badiee, M | 1 |
| Afrasiabi, MA | 1 |
| Haghpanah, S | 1 |
| Brock, G | 1 |
| Vardi, Y | 1 |
| Chen, J | 1 |
| Hatzimouratidis, K | 1 |
| Sohn, M | 1 |
| Cockerham, YR | 1 |
| Heidari, M | 1 |
| Nejadi, JR | 1 |
| Ghate, A | 1 |
| Delfan, B | 1 |
| Iran-Pour, E | 1 |
| Gur, S | 1 |
| Limin, M | 1 |
| Moskovic, DJ | 1 |
| Alex, B | 1 |
| Choi, JM | 1 |
| Nelson, CJ | 1 |
| Mulhall, JP | 6 |
| D'Ascenzo, R | 2 |
| Nupieri, P | 2 |
| De Giorgio, G | 2 |
| Orsolini, G | 2 |
| Abern, MR | 1 |
| Larsen, S | 1 |
| Halal, AA | 1 |
| Geavlete, P | 1 |
| Ceban, E | 1 |
| Costabile, RA | 1 |
| Garrido Abad, P | 1 |
| Coloma, A | 1 |
| Herranz, LM | 1 |
| Jiménez, M | 1 |
| Suárez, C | 1 |
| Prieto, MD | 1 |
| Formoso, T | 1 |
| Fernández Arjona, M | 1 |
| Garcia, F | 1 |
| Young, LD | 1 |
| Solomon, M | 1 |
| Brock, GB | 1 |
| Mehrsai, AR | 1 |
| Namdari, F | 1 |
| Salavati, A | 1 |
| Dehghani, S | 1 |
| Allameh, F | 1 |
| Pourmand, G | 1 |
| Stein, A | 1 |
| Dekel, Y | 1 |
| Goldman, KE | 1 |
| Greenfield, JM | 2 |
| Imbimbo, C | 2 |
| Longo, N | 1 |
| Fusco, F | 2 |
| Tajana, G | 1 |
| Martin, DJ | 1 |
| Badwan, K | 1 |
| Parker, M | 1 |
| Estrada, CR | 2 |
| Shou, W | 1 |
| Cole, A | 1 |
| Di Stasi, SM | 2 |
| Giannantoni, A | 2 |
| Capelli, G | 2 |
| Jannini, EA | 2 |
| Virgili, G | 1 |
| Storti, L | 1 |
| Vespasiani, G | 2 |
| Ralph, DJ | 1 |
| Minhas, S | 1 |
| Stephen, RL | 1 |
| Giurioli, A | 1 |
| Ohebshalom, M | 1 |
| Russell, S | 1 |
| Steers, W | 1 |
| McVary, KT | 1 |
| Akin-Olugbade, Y | 1 |
| Shah, SJ | 1 |
| Fitch, WP | 1 |
| Easterling, WJ | 1 |
| Talbert, RL | 1 |
| Bordovsky, MJ | 1 |
| Mosier, M | 1 |
| Modenini, F | 1 |
| Vitali, G | 2 |
| Bennett, NE | 1 |
| Guhring, P | 1 |
| Levine, L | 1 |
| Merrick, PF | 1 |
| Lee, RC | 1 |
| Arena, F | 1 |
| Peracchia, G | 1 |
| Di Stefano, C | 1 |
| Passari, A | 1 |
| Larosa, M | 1 |
| Cortellini, P | 1 |
| Treffiletti, S | 1 |
| Annoscia, S | 1 |
| Montefiore, F | 1 |
| Boccafoschi, C | 1 |
| Rehman, J | 1 |
| Benet, A | 1 |
| Melman, A | 1 |
| Lasser, A | 1 |
| Vandenberg, TL | 1 |
| Vincent, MJ | 1 |
| Mantovani, F | 1 |
| Patelli, E | 1 |
| Colombo, F | 1 |
| Riedl, CR | 1 |
| Plas, E | 1 |
| Engelhardt, P | 1 |
| Daha, K | 1 |
| Pflüger, H | 1 |
| Anderson, MS | 1 |
| Shankey, TV | 1 |
| Lubrano, T | 1 |
| Biagiotti, G | 1 |
| Koverech, A | 1 |
19 reviews available for verapamil and Penile Induration
| Article | Year |
|---|---|
Non-surgical therapies for Peyronie's disease.
Topics: Erectile Dysfunction; Humans; Male; Pain; Penile Induration; Quality of Life; Randomized Controlled | 2023 |
A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
Topics: Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Penile Induration; Penis; Sexual | 2019 |
Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Topics: Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Penile Induration; Treatment Outc | 2020 |
Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Topics: Adult; Humans; Hyaluronic Acid; Injections, Intralesional; Interferon alpha-2; Male; Microbial Colla | 2019 |
Minimally invasive treatment of Peyronie's disease: evidence-based progress.
Topics: 4-Aminobenzoic Acid; Administration, Oral; Calcium Channel Blockers; Carnitine; Colchicine; Evidence | 2014 |
Update on medical management of Peyronie's disease.
Topics: 4-Aminobenzoic Acid; Administration, Topical; Adrenal Cortex Hormones; Disease Management; High-Ener | 2014 |
2013-2014 updates in Peyronie's disease management.
Topics: Humans; Male; Penile Induration; Practice Guidelines as Topic; Urologic Surgical Procedures, Male; V | 2014 |
Peyronie's Disease: Intralesional Therapy and Surgical Intervention.
Topics: Calcium Channel Blockers; Humans; Interferon alpha-2; Interferon-alpha; Male; Microbial Collagenase; | 2016 |
Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options.
Topics: 4-Aminobenzoic Acid; Colchicine; Collagenases; Drug Administration Routes; Humans; Interferon-alpha; | 2011 |
Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
Topics: Animals; Colchicine; Humans; Inflammation; Male; Oxidative Stress; Penile Induration; Penis; Reactiv | 2012 |
[Review of Peyronie's disease].
Topics: Colchicine; Humans; Injections, Intralesional; Male; Penile Induration; Tamoxifen; Verapamil; Vitami | 2012 |
Intralesional verapamil for the treatment of Peyronie's disease: a review.
Topics: Calcium Channel Blockers; Disease Progression; Humans; Injections, Intralesional; Male; Penile Indur | 2002 |
Review of current nonsurgical management of Peyronie's disease.
Topics: Antioxidants; Calcium Channel Blockers; Colchicine; Collagenases; Drug Therapy, Combination; Humans; | 2003 |
The management of Peyronie's disease.
Topics: 4-Aminobenzoic Acid; Colchicine; Humans; Interferon alpha-2; Interferon-alpha; Lithotripsy; Male; Pe | 2004 |
Towards an evidence-based understanding of Peyronie's disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Evidence-Based Medicine; Fibroblasts; Huma | 2005 |
Transdermal and topical pharmacotherapy for male sexual dysfunction.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Androgens; Animals; Erectile Dysfun | 2005 |
Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease.
Topics: Adrenal Cortex Hormones; Collagenases; Evidence-Based Medicine; Humans; Injections, Intralesional; I | 2007 |
The medical management of Peyronie's disease.
Topics: Adrenal Cortex Hormones; Disease Management; Drug Therapy, Combination; Humans; Male; Penile Indurat | 2007 |
Advances in the medical therapy of Peyronie's disease: a brief review.
Topics: Colchicine; Collagenases; Humans; Male; Penile Induration; Verapamil | 1998 |
23 trials available for verapamil and Penile Induration
| Article | Year |
|---|---|
Intralesional collagenase
Topics: Humans; Injections, Intralesional; Male; Microbial Collagenase; Patient Satisfaction; Penile Indurat | 2022 |
Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Topics: Adult; Aged; Double-Blind Method; Humans; Hyaluronic Acid; Injections, Intralesional; Italy; Male; M | 2017 |
Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study.
Topics: Adult; Aged; Antioxidants; Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Middle | 2014 |
Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study.
Topics: Adult; Aged; Aged, 80 and over; Blueberry Plants; Case-Control Studies; Diclofenac; Humans; Inflamma | 2013 |
Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Iran; Male; Middle Aged; Pain; | 2014 |
The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Calcium Channel Blockers; Dexameth | 2009 |
Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
Topics: Calcium Channel Blockers; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; P | 2009 |
Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
Topics: Adult; Aged; Humans; Male; Middle Aged; Penile Induration; Surveys and Questionnaires; Treatment Out | 2010 |
Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.
Topics: Administration, Oral; Age Factors; Combined Modality Therapy; Humans; Injections, Intralesional; Mal | 2012 |
Pharmacological therapy in patients diagnosed with Peyronie's disease.
Topics: Adult; Aged; Colchicine; Drug Therapy, Combination; Humans; Male; Middle Aged; Penile Induration; Ve | 2012 |
Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Anthocyanins; Antioxidants; Biological Therapy; Chronic Disease; D | 2013 |
Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blueberry Plants; Cal | 2013 |
Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
Topics: Administration, Cutaneous; Analysis of Variance; Calcium Channel Blockers; Dexamethasone; Drug Thera | 2013 |
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Topics: Administration, Cutaneous; Calcium Channel Blockers; Dexamethasone; Electricity; Humans; Male; Middl | 2004 |
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Topics: Double-Blind Method; Humans; Iontophoresis; Male; Middle Aged; Patient Satisfaction; Penile Erection | 2007 |
Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administ | 2007 |
Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; In | 2007 |
Intralesional verapamil prevents the progression of Peyronie's disease.
Topics: Adult; Disease Progression; Follow-Up Studies; Humans; Injections, Intralesional; Male; Middle Aged; | 2007 |
Treatment of Peyronie's disease with intralesional verapamil injection.
Topics: Adult; Aged; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; Prospective St | 1997 |
Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Topics: Adult; Aged; Calcium Channel Blockers; Clinical Protocols; Humans; Injections, Intralesional; Male; | 1998 |
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica.
Topics: Adult; Combined Modality Therapy; Erectile Dysfunction; High-Energy Shock Waves; Humans; Male; Middl | 1999 |
Iontophoresis for treatment of Peyronie's disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Dexamethasone; Humans; Iontophoresis; Lidocaine; Male; Middle | 2000 |
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2002 |
26 other studies available for verapamil and Penile Induration
| Article | Year |
|---|---|
A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease.
Topics: Humans; Injections, Intralesional; Male; Penile Induration; Verapamil | 2023 |
Verapamil and collagenase differentially affect collagen metabolism in experimental model of Peyronie's disease.
Topics: Animals; Cell Line; Cell Movement; Cell Survival; Collagen; Dipeptidases; DNA; Fibroblasts; Humans; | 2020 |
Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Topics: Acute Disease; Administration, Oral; Arginine; Clinical Protocols; Combined Modality Therapy; Drug A | 2019 |
Intralesional Injections for Early Peyronie Disease: Standardized Assessment and Analysis of Predictive Factors for Treatment Response.
Topics: Dose-Response Relationship, Drug; Early Diagnosis; Humans; Injections, Intralesional; Male; Middle A | 2015 |
[La Peyronie disease, erectile dysfunction, kidney tumors]].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Biopsy; Erectile Dysfunction; Follow-Up Studies; Human | 2008 |
Clinical case: 45-year-old male with penile pain (CME).
Topics: Anthropometry; Cicatrix; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Induration; Phospho | 2009 |
Is there a place for conservative treatment in Peyronie's disease?
Topics: Administration, Topical; Expert Testimony; Gels; Humans; Iontophoresis; Male; Penile Induration; Pen | 2009 |
Intralesional injection therapy for Peyronie's disease.
Topics: Anesthetics, Local; Angiogenesis Inhibitors; Humans; Injections, Intralesional; Interferon alpha-2; | 2009 |
Current approach to the man with acute phase Peyronie's disease--case presentation and discussion.
Topics: Adult; Arginine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; H | 2011 |
Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.
Topics: Age Factors; Forecasting; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; R | 2011 |
Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
Topics: Adult; Aged; Antioxidants; Blueberry Plants; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Di | 2012 |
Is intralesional verapamil effective therapy for Peyronie's disease?
Topics: Humans; Injections, Intralesional; Male; Penile Induration; Verapamil | 2012 |
Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Calcium Channel Blockers; Coitus; | 2012 |
A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcome.
Topics: Animals; Disease Models, Animal; Immunohistochemistry; Injections, Intralesional; Male; Penile Erect | 2013 |
Experience with intraplaque injection of verapamil for Peyronie's disease.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Int | 2002 |
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy.
Topics: Adult; Aged; Biopsy, Needle; Calcium Channel Blockers; Humans; Male; Middle Aged; Penile Induration; | 2002 |
Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea.
Topics: Absorption; Administration, Cutaneous; Calcium Channel Blockers; Gels; Humans; Male; Penile Indurati | 2002 |
Tunica albuginea tissue analysis after electromotive drug administration.
Topics: Drug Administration Routes; Electricity; Epinephrine; Humans; Male; Penile Induration; Penis; Tissue | 2003 |
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Topics: Administration, Cutaneous; Adult; Aged; Dexamethasone; Drug Combinations; Erectile Dysfunction; Huma | 2003 |
Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'.
Topics: Administration, Topical; Adult; Double-Blind Method; Humans; Magnesium Sulfate; Male; Penile Erectio | 2007 |
Intralesional verapamil injection for the treatment of Peyronie's disease.
Topics: Adult; Aged; Follow-Up Studies; Humans; Injections, Intralesional; Male; Middle Aged; Penile Indurat | 1994 |
[Clinical effects of verapamil in the treatment of Peyronie's disease].
Topics: Calcium Channel Blockers; Humans; Male; Penile Induration; Retrospective Studies; Verapamil | 1995 |
[Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience].
Topics: Anti-Inflammatory Agents; Dexamethasone; Evaluation Studies as Topic; Follow-Up Studies; Humans; Ion | 1997 |
Intraplaque verapamil injection for treatment of Peyronie's disease.
Topics: Adult; Calcium Channel Blockers; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Pain Meas | 1998 |
[Correction of acquired penile curvatures].
Topics: Calcinosis; Fibrosis; Humans; Male; Penile Induration; Penile Prosthesis; Penis; Prosthesis Design; | 1998 |
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents.
Topics: Alprostadil; Antiviral Agents; Calcium Channel Blockers; Cell Separation; Cells, Cultured; Colchicin | 2000 |